Tech Journal of Colorado
SEE OTHER BRANDS

Get your fresh news on science and technology in Colorado

Tech Journal of Colorado: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Journal of Colorado.

Press releases published on August 13, 2025

Space Force Association Announces Lieutenant General Philip A. Garrant as Featured Speaker at Spacepower Conference

Space Force Association Announces Lieutenant General Philip A. Garrant as Featured Speaker at Spacepower Conference

SFA announces Lieutenant General Philip A. Garrant, Commander, Space Systems Command at the United States Space Force, as Spacepower Conference featured speaker COLORADO SPRINGS, CO, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- The Space Force …

Smarter Home Search Comes to Colorado as Houzeo Launches 'Save Search' and Custom Alerts

Smarter Home Search Comes to Colorado as Houzeo Launches 'Save Search' and Custom Alerts

Houzeo enhances the home search experience in Colorado by allowing buyers to save custom searches and get instant alerts for every area they follow. DENVER, CO, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Houzeo, America’s Real Estate Super App …

Pitcher Recognized in Five Gartner® Hype Cycle Reports ™ for Summer 2025

Pitcher Recognized in Five Gartner® Hype Cycle Reports ™ for Summer 2025

DENVER, CO, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Gartner has recognized Pitcher’s Sales Enablement 2.0 platform in five Gartner Hype Cycles published in July 2025. “Gartner Hype Cycles provide a graphic representation of the maturity …

Ashish Kothari’s TEDx Talk Challenges the World to Make Flourishing a Competitive Edge

Ashish Kothari’s TEDx Talk Challenges the World to Make Flourishing a Competitive Edge

BOULDER, CO, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- Ashish Kothari, Founder and CEO of Happiness Squad, has released his much anticipated TEDx talk, “How to Make Flourishing Your Competitive Edge,” which is a bold call to transform the way …

Eightfold AI Recognized as One of HR Executive Magazine’s 2025 Products of the Year

Eightfold AI Recognized as One of HR Executive Magazine’s 2025 Products of the Year

SANTA CLARA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Eightfold AI has been named to the 2025 Products of the Year list by HR Executive Magazine and the HR Technology Conference. This annual competition, widely regarded as a benchmark for innovation and …

Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition

Enovix Shareholder Third Reminder: Early Warrant Expiration Price Condition

FREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (Nasdaq: ENVX, ENVXW) (“Company” or “Enovix”), a leader in advanced silicon battery technology, today announced that the price of its common stock has exceeded $10.50 for seventeen …

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the …

Applied Therapeutics Reports Second Quarter 2025 Financial Results

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD - Presented full 12-month clinical results and new topline data from INSPIRE Phase 2/3 trial of govorestat for the treatment of CMT- …

Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details

Quorum Announces Q2 2025 Results Release Date, Conference Call and Webcast Details

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Quorum Information Technologies Inc. (TSX-V: QIS) (“Quorum”), a North American SaaS Software and Services company providing essential enterprise solutions that automotive dealerships and Original …

LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update

LAVA Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Announced entry into an agreement to be acquired by XOMA Royalty Corporation for between $1.16 and $1.24 per share in cash, plus a contingent value right related to LAVA’s two partnered assets and unpartnered programs Consummation of acquisition expected …

Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

Astrotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference in September 2025

AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) today announced that Thomas B. Pickens III, Chairman and Chief Executive Officer, and Jennifer Cañas, Chief Financial Officer, will host …

USA Carter Valve Unveils CARTERUS Series for Critical Industries

USA Carter Valve Unveils CARTERUS Series for Critical Industries

New series features six-eccentric tech for extreme temps/cryogenics and a triple-offset valve for ultra-high pressure, offering a total solution. DENVER, CO, UNITED STATES, August 13, 2025 /⁨EINPresswire.com⁩/ -- USA Carter Valve Inc., a Colorado-based …

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

SCYNEXIS Reports Second Quarter 2025 Financial Results and Provides Corporate Update

First new patient dosed in Phase 3 MARIO study following the lifting of the FDA clinical hold, triggering a $10M milestone payment from GSK. An additional $20M milestone will be triggered upon the six month anniversary of the new patient dosing; as …

Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider

Onco360 adds Modeyso™ (dordaviprone) to portfolio of Oncology and Rare Cancer therapies as a National Specialty Pharmacy Provider

LOUISVILLE, Ky., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a pharmacy partner by Jazz Pharmaceuticals for Modeyso™ (dordaviprone). It is indicated for the treatment of adult and …

Aptose Reports Second Quarter 2025 Results

Aptose Reports Second Quarter 2025 Results

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at 120 mg Dose Cohort Safety Review Committee (CSRC) Recommends Tuspetinib Dose Escalation to 160 …

Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update

Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update

- Positive 12-month Phase 1/2 clinical data in adult cohort and early pediatric clinical data support potential for meaningful vision restoration with OPGx-LCA5 - - FDA grants Regenerative Medicine Advanced Therapy (RMAT) designation for OPGx-LCA5 - - …

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Vivani Medical Provides Business Update Including $10M Equity Financing and Reports Second Quarter 2025 Financial Results

Company plans rapid advancement of semaglutide implant NPM-139, following positive weight loss data from an ongoing preclinical study of NPM-139 and promising results from the LIBERATE-1 Phase 1 clinical study of NPM-115 New $10M equity financing to enable …

Orezone Gold Reports Second Quarter 2025 Results

Orezone Gold Reports Second Quarter 2025 Results

All dollar amounts are in USD unless otherwise indicated and abbreviation “M” means million. VANCOUVER, British Columbia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX/ASX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) is pleased to report …

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Alvotech Reports Results for the First Six Months of 2025 and Provides a Business Update

Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for pipeline assets Alvotech listed on Nasdaq Stockholm Market …

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights

Continued advancement of two clinical-stage assets, both with clinically demonstrated single-agent anti-tumor activity -- ACR-368 in a registrational-intent Phase 2 study in endometrial cancer and ACR-2316 in a Phase 1 study in AP3-predicted tumor types …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions